GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6B
GSK is making one of the largest biotech acquisitions in its history to gain access to two experimental lung cancer medicines due for FDA approval decisions lat...
GSK is making one of the largest biotech acquisitions in its history to gain access to two experimental lung cancer medicines due for FDA approval decisions later this year. The UK drugmaker plans to acquire ...